NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.and NeutroPhase, used in treatment of Necrotizing Fasciitis
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - NovaBay Pharmaceuticals (en)
|
rdfs:comment
| - NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.and NeutroPhase, used in treatment of Necrotizing Fasciitis (en)
|
foaf:name
| - NovaBay Pharmaceuticals, Inc. (en)
|
name
| - NovaBay Pharmaceuticals, Inc. (en)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
foundation
| |
founder
| |
key people
| - Glenn Moro, VP, Marketing Avenova (en)
- Greg Miller, Director, Strategic Sales (en)
- John McGovern, CFO (en)
- Lewis J. Stuart, M.B.A., Chief Commercial Officer (en)
- Mark Sieczkarek, M.B.A., CEO and Chairman of BOD (en)
- Tom Paulson, M.B.A., Strategic Planning (en)
- Justin M. Hall, Esq, Senior Vice President, General Counsel (en)
|
logo
| - NovaBay Pharmaceuticals Logo.jpg (en)
|
logo size
| |
traded as
| - Russell Microcap Index component (en)
|
type
| |
has abstract
| - NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.and NeutroPhase, used in treatment of Necrotizing Fasciitis (en)
|
skos:closeMatch
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
founding year
| |
type
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |